
WAY Stock Forecast & Price Target
WAY Analyst Ratings
Bulls say
Waystar Holding is viewed favorably because its mission-critical cloud platform addresses rising healthcare revenue cycle complexity with end-to-end automation that improves claim accuracy, data integrity, and reimbursement speed while reducing labor costs. The company’s 3Q26 results reinforced that view, with revenue of $325.6M, adjusted EBITDA of $139.3M, a 42.8% margin, 25% YTD bookings growth, and free cash flow of $115M, alongside a 107.6% NRR and 1,488 clients generating more than $100K in trailing revenue. Fundamental support also comes from strong cross-sell and platform adoption, including its largest-ever new client, while management raised 2026 adjusted EBITDA guidance to $543M-$549M even as revenue conversion lags on longer implementation ramps.
Bears say
Waystar Holding is viewed negatively because its revenue cycle management market is highly competitive and fragmented, with entrenched players like Epic and Cerner and emerging AI-based rivals able to pressure share, slow growth, and weaken margins. Management also highlighted elongated enterprise sales cycles of 12–18 months in the hospital segment, while the 3Q adj. EBITDA of $193M and a 2026 guide of $543M-$549M were offset by a narrowed and slightly lowered revenue outlook, signaling timing friction and less robust near-term revenue momentum. Additional downside comes from cybersecurity breach exposure, a financially unstable end market, high indebtedness, potential client losses, and the overhang of current PE/VC ownership.
This aggregate rating is based on analysts' research of Waystar Holding Corp and is not a guaranteed prediction by Public.com or investment advice.
WAY Analyst Forecast & Price Prediction
Start investing in WAY
Order type
Buy in
Order amount
Est. shares
0 shares
FAQs About Waystar Holding Corp (WAY) Forecast
WAY Analyst Forecast & Price Prediction
Start investing in WAY
Order type
Buy in
Order amount
Est. shares
0 shares